Free tool
FAERS Monitor: Digoxin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021648 or its brand name (Digoxin, Digoxin). Reports on generic versions are filed under their own applications.
Reports
62,828
Serious
52,124
83% of reports
Hospitalization
31,923
Death reported
12,311
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea5,634
- nausea4,389
- dizziness4,165
- fatigue3,918
- atrial fibrillation3,649
- diarrhoea3,506
- asthenia3,153
- vomiting3,087
- death3,063
- hypotension2,926
- pain2,780
- fall2,659
- cardiac failure congestive2,651
- drug interaction2,515
- pneumonia2,480
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,977 |
| 2005 | 1,966 |
| 2006 | 1,914 |
| 2007 | 1,652 |
| 2008 | 4,059 |
| 2009 | 3,129 |
| 2010 | 2,884 |
| 2011 | 3,444 |
| 2012 | 3,505 |
| 2013 | 2,894 |
| 2014 | 3,567 |
| 2015 | 3,831 |
| 2016 | 3,844 |
| 2017 | 3,589 |
| 2018 | 3,457 |
| 2019 | 2,941 |
| 2020 | 2,712 |
| 2021 | 2,113 |
| 2022 | 1,733 |
| 2023 | 2,175 |
| 2024 | 2,038 |
| 2025 | 1,994 |
| 2026 | 1,403 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,331 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| atrial fibrillationSignal | 3,649 | 13.0 | 12.6 | 39,049 |
| cardiac failure congestiveSignal | 2,651 | 11.4 | 11.0 | 24,380 |
| drug interactionSignal | 2,515 | 5.4 | 5.2 | 8,880 |
| hypotensionSignal | 2,926 | 4.9 | 4.8 | 9,146 |
| dyspnoeaSignal | 5,634 | 3.4 | 3.3 | 9,474 |
| astheniaSignal | 3,153 | 2.8 | 2.7 | 3,744 |
| dizzinessSignal | 4,165 | 2.8 | 2.7 | 4,933 |
| fallSignal | 2,659 | 2.7 | 2.6 | 2,839 |
| pneumoniaSignal | 2,480 | 2.6 | 2.5 | 2,409 |
| vomitingSignal | 3,087 | 2.2 | 2.1 | 2,067 |
| nausea | 4,389 | 1.9 | 1.8 | 1,806 |
| diarrhoea | 3,506 | 1.8 | 1.8 | 1,335 |
| fatigue | 3,918 | 1.7 | 1.6 | 1,135 |
| pain | 2,780 | 1.5 | 1.5 | 502 |
| death | 3,063 | 1.2 | 1.2 | 97 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.